IsoDMT

Serotonergic drug From Wikipedia, the free encyclopedia

isoDMT, also known as N,N-dimethylisotryptamine, is a putatively non-hallucinogenic serotonin 5-HT2A receptor agonist and psychoplastogen of the isotryptamine group.[1][2][3][4][5][6] It is the isotryptamine homologue of dimethyltryptamine (DMT), a more well-known serotonergic psychedelic of the tryptamine family, and represents a small structural modification of DMT.[2][3][6]

Other namesiso-DMT; N,N-Dimethylisotryptamine; iso-N,N-DMT; N,N-Dimethylaminoisotryptamine; Dimethylaminoisotryptamine
CAS Number
Quick facts Clinical data, Other names ...
isoDMT
Clinical data
Other namesiso-DMT; N,N-Dimethylisotryptamine; iso-N,N-DMT; N,N-Dimethylaminoisotryptamine; Dimethylaminoisotryptamine
Drug classNon-hallucinogenic serotonin 5-HT2A receptor agonist; Psychoplastogen
Identifiers
  • 2-indol-1-yl-N,N-dimethylethanamine
CAS Number
PubChem CID
ChemSpider
ChEMBL
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC12H16N2
Molar mass188.274 g·mol−1
3D model (JSmol)
  • CN(C)CCN1C=CC2=CC=CC=C21
  • InChI=1S/C12H16N2/c1-13(2)9-10-14-8-7-11-5-3-4-6-12(11)14/h3-8H,9-10H2,1-2H3
  • Key:PSHKCPACSIZILK-UHFFFAOYSA-N
Close

Pharmacology

Pharmacodynamics

isoDMT does not produce hallucinogen-like stimulus generalization in animal drug discrimination tests and similarly does not produce the head-twitch response, an animal behavioral proxy of psychedelic-like effects.[1][2][4][6] As such, it is not expected to be hallucinogenic in humans.[1][2][4][6] However, isoDMT retains significant activity at the serotonin 5-HT2 receptors and shows psychoplastogenic effects comparable to those of serotonergic psychedelics in preclinical research.[7][6][8][9] Its affinities (Ki) for the serotonin 5-HT2 receptors have been reported to be 600–650 nM for 5-HT2A and 720 nM at 5-HT2C.[9]

Chemistry

Analogues

Several derivatives of isoDMT have been developed, including the non-hallucinogenic psychoplastogens 5-MeO-isoDMT and zalsupindole (DLX-001; AAZ-A-154; (R)-5-MeO-α-methyl-isoDMT) and the hallucinogen and psychoplastogen 6-MeO-isoDMT.[1][10][7][6] Zalsupindole has shown antidepressant-like effects in animals, thought to be secondary to its psychoplastogenic actions, and is under development for potential medical use to treat neuropsychiatric disorders like depression.[1][11][12][13] Another analogue of isoDMT is α-methylisotryptamine (isoAMT), the isotryptamine homologue of α-methyltryptamine (AMT).[14][15][16]

History

isoDMT and its derivatives were first described in the scientific literature by 1984.[1][8][10] They were subsequently further characterized in 2020.[7][6]

See also

References

Related Articles

Wikiwand AI